What is the main business of Innovative Dietary Supplements?

The main business activity of Innovative Dietary Supplements focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 30, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Kolejowa 10A, 23-200 Kraśnik.

What is the share capital?

The share capital of the company is PLN 7,500 (approx. $2,026).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

The company reported a revenue of $28,408 in 2024, which is a decrease of 25.7% compared to 2023.

Yes, in 2024 the company was profitable, achieving a net profit of $1,637.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $26,299 in 2024, representing 100% of all operating expenses.

Innovative Dietary Supplementssp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-09-30

Share capital

7,500.00 PLN

Registered address

ul. Kolejowa 10A, 23-200 Kraśnik, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 5 financial statements were filed late (the longest delay 279 days for 2021).

2025not filed
202412/03/2026
202304/11/2024
202206/06/2023
202120/04/2023
202012/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Manufacture of pharmaceutical preparations210 / 258

Top 81%

Division · Manufacture of basic pharmaceutical products and pharmaceutical preparations262 / 330

Top 79%

Sector · Manufacturing28,499 / 33,747

Top 84%

Voivodeship · Lubelskie11,866 / 15,983

Top 74%

Country · Poland368,523 / 495,867

Top 74%

Results vs industry

Revenue

This companyUSD 28.41kMedianUSD 919.05kAverageUSD 25.83m

Net profit

This companyUSD 1.64kMedianUSD 14.92kAverageUSD 2.77m

Operating costs

This companyUSD 26.32kMedianUSD 873.06kAverageUSD 21.43m

Assets

This companyUSD 13.72kMedianUSD 897.46kAverageUSD 31.52m

Industry

Authorized Representatives

Mateusz Artur Rogóż – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Infini sp. z o.o.	45	$607.78	30%
Mateusz Artur Rogóżage 32	105	$1,418.15	70%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2021-01-01.

mBank
21 1140 2004 0000 3802 8057 6846
mBank
75 1140 2004 0000 3202 8057 6847

Debt

No entries in the National Debtors Register (KRZ).

Public aid

Grant date	Purpose	Gross amount	Granting body
Nov 18, 2020	Aid for SME access to finance — aid for start-ups	$215.4K$215,396	Dyrektor Narodowego Centrum Badań i Rozwoju
Nov 18, 2020	Aid for SME access to finance — aid for start-ups	$215.4K$215,396	Dyrektor Narodowego Centrum Badań i Rozwoju

Competitors

Name	Revenue	Website
Przedsiębiorstwo Farmaceutyczne Leki Natury Tadeusz Polańskisp. z o.o.	$893,738.50	lekinatury.pl
LideoS.A.	$95,067.91	lideo.tech
Munar PharmaS.A.	$85,649.72	munar.pl
BIO Animalisp. z o.o.	$49,176.96	proanimali.com
Ampliconsp. z o.o.	$48,330.99	amplicon.pl
Xenira Pharmaceuticalssp. z o.o.	$26,670.82	xenirapharma.com
Sanford Biotechsp. z o.o.	$2,586.64	sanfordbiotech.com
Cefeasp. z o.o.	$294.66	cefea.pl
Auxilius PharmaS.A.	$0.83	auxiliuspharma.com
Powerpharmasp. z o.o.	–	powerpharma.eu